Department of Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9110, USA.
J Urol. 2010 Jan;183(1):302-5. doi: 10.1016/j.juro.2009.09.001.
Extant literature is mixed regarding risk of metabolic acidosis after enteroplasty for myelomeningocele. This study is the first known attempt to describe the pattern of developing metabolic acidosis in a group of children who underwent enteroplasty and served as their own controls. Multiple preoperative and postoperative laboratory measures for each child were obtained for comparison.
This retrospective cohort study allowed participants to serve as their own controls for pre-intervention and post-intervention analysis. The setting was a tertiary, university affiliated, interdisciplinary spina bifida program. All patients followed in the spina bifida program who had undergone ileal or colonic enteroplasty were included for review (total 113). Strict exclusion criteria were preoperatively diagnosed renal insufficiency, preexisting metabolic acidosis consistent with renal tubular acidosis (pH less than 7.35, bicarbonate 20 mmol/l or less) and history of augmentation using gastric or ureteral tissue. Final analysis included 71 children who met inclusion criteria. Children in our spina bifida program periodically undergo routine laboratory evaluation of electrolytes, blood urea nitrogen, creatinine, blood count, and venous blood gases including pH, bicarbonate and partial pressure of carbon dioxide. Primary outcome measures were comparative shifts in blood gases and electrolytes that would confirm the new onset of metabolic acidosis after enteroplasty. Changes in electrolytes and serum creatinine were secondary outcome measures to identify potential markers for postoperative effects. With each child as his/her own control, analysis included paired t tests.
No statistically significant differences (p <0.05) were found when comparing laboratory values before and after bladder augmentation, including pH, bicarbonate, partial pressure of carbon dioxide and electrolytes. No child had metabolic acidosis based on the aforementioned criteria. Followup ranged from 1 to 138 months after enteroplasty (mean 46.8). Respiratory compensation was considered in the analysis, and no difference in partial pressure of carbon dioxide following surgery was noted (p = 0.65).
To our knowledge no previous study has examined the matched paired results of before and after development of metabolic acidosis among children (serving as their own controls) with myelomeningocele undergoing ileal or colonic enteroplasty. The negative statistical results in this controlled cohort are clinically significant. If a child with myelomeningocele has metabolic acidosis after enteroplasty, other clinical reasons beyond the effects of surgery warrant careful consideration.
关于脑脊膜膨出患儿肠成形术后发生代谢性酸中毒的风险,现有文献的结论不一。本研究首次尝试描述一组接受肠成形术并作为自身对照的患儿发生代谢性酸中毒的模式。对每个患儿的多项术前和术后实验室指标进行了比较。
本回顾性队列研究允许参与者对术前和术后进行自身对照分析。该研究的地点是一家三级、大学附属的跨学科脊柱裂项目。所有在脊柱裂项目中接受回肠或结肠肠成形术的患者都被纳入研究(共 113 例)。严格的排除标准是术前诊断为肾功能不全、术前存在符合肾性肾小管酸中毒的代谢性酸中毒(pH 值<7.35,碳酸氢盐<20mmol/L)和使用胃或输尿管组织进行过增强手术的病史。最终分析纳入了符合纳入标准的 71 名患儿。我们的脊柱裂项目中的患儿定期进行常规的电解质、血尿素氮、肌酐、血常规和静脉血气分析,包括 pH 值、碳酸氢盐和二氧化碳分压。主要观察指标是比较肠成形术后血液气体和电解质的变化,以确定代谢性酸中毒的新发病例。电解质和血清肌酐的变化是次要观察指标,以确定术后影响的潜在标志物。对每个患儿作为自身对照进行分析,包括配对 t 检验。
在比较膀胱增强前后的实验室值时,包括 pH 值、碳酸氢盐、二氧化碳分压和电解质,均未发现统计学差异(p<0.05)。根据上述标准,没有患儿发生代谢性酸中毒。肠成形术后的随访时间为 1 至 138 个月(平均 46.8 个月)。在分析中考虑了呼吸代偿,手术后二氧化碳分压无差异(p=0.65)。
据我们所知,尚无研究检查过患有脑脊膜膨出的患儿(作为自身对照)在接受回肠或结肠肠成形术后发生代谢性酸中毒的配对结果。该对照队列的阴性统计结果具有重要的临床意义。如果患有脑脊膜膨出的患儿在肠成形术后发生代谢性酸中毒,除手术影响外,还需要仔细考虑其他临床原因。